Dr Bożena Walewska-Zielecka becomes new Medical Director and joins the Medicover Board

Dr Bożena Walewska-Zielecka becomes new Medical Director and joins the Medicover Board

Published

In June of this year, Dr Bożena Walewska-Zielecka was appointed to the Management Board of Medicover Sp. z o.o. and took over the post of Medical Director at Medicover. In her new role she will be responsible for medical quality, occupational medicine, prevention standards and the quality and risk management system, among others.

Dr Bożena Walewska-Zielecka became a new member of the Management Board of Medicover Sp. z o.o. At the same time, she assumed the position of Medical Director. Previously, she served as Deputy Clinical Director. She has been with Medicover since 1995.

The many years of experience gained at our company guarantees an excellent understanding of its functioning, priorities and key needs. Dr Bożena Walewska-Zielecka’s knowledge of Medicover combined with her medical and managerial experience will support the effective development of her department, 

comments Mirosław Suszek, Vice President of the Management Board, Director of Operations and Medical Division at Medicover Polska.

Bożena Walewska-Zielecka holds a PhD degree in medical sciences, is a pathologist, travel medicine physician and a specialist in liver disease. She also gained broad experience as a lecturer and researcher at Warsaw Medical University.
At the same time, Dr Piotr Soszyński took over the newly created position of Director of Medical Systems. He will be responsible for the maintenance and development of medical systems, supervising authorisations and access to the systems, as well as information security, including protecting medical information, along with the necessary adaptations to the new EU legal requirements, and cooperation with other innovation development teams.

Copy as a Plain Text

Share

Related Stories
Healthy baby - the challenge of modern times

ago

In 2016, over 382,000 births were recorded in Poland [1]. Research shows that two thirds of parents feed their children the wrong diet and expand their children’s diet too quickly [2]. The knowledge on how to take proper care of infants is still insufficient, which increases the risk of disease in later years. That is why regular medical check-ups for a newborn baby are so important to ensure that his health and development are constantly assessed. Constant paediatric care also enables parents to deepen their knowledge about the best ways to take care of their child's health.
Medicover first in Europe to launch pilot project aimed at identifying patients at risk of colorectal cancer

ago

Medicover Polska is testing the ColonFlag modern solution that will allow to effectively identify patients at risk for colorectal cancer. The tool determines the risk of intestinal lesions by further analysing the results of a commonly performed blood test. The pilot project is being developed in collaboration with Medial EarlySign, an Israeli company that creates machine-learning systems in the area of data-driven medicine.
Nearly one in four Poles have thyroid dysfunction

ago

On one hand, weakness, excessive sleepiness, prone to freezing, weight gain and apathy. On the other, insomnia, feeling hot, weight loss, nervousness and irritability. All these symptoms can point to the dysfunction of the same gland - the thyroid. Experts estimate that more than 300 million people worldwide suffer from thyroid problems, but as many as half of them are not aware of the illness.
Medicover launches Health Innovators. Takes another step towards innovation.

ago

Medicover has launched a unit dedicated to healthcare innovation and collaboration with startups – Health Innovators by Medicover. It is a team whose mission is to implement innovative medical projects. As part of the project the company wants to build a community of innovators - made up of startups, patients and employees - and thus speed up the implementation of new solutions.

Medicover first in Europe to launch pilot project aimed at identifying patients at risk of colorectal cancer

Medicover Polska is testing the ColonFlag modern solution that will allow to effectively identify patients at risk for colorectal cancer. The tool determines the risk of intestinal lesions by further analysing the results of a commonly performed blood test. The pilot project is being developed in collaboration with Medial EarlySign, an Israeli company that creates machine-learning systems in the area of data-driven medicine.